These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21895712)

  • 1. Comparison of alcoholism subtypes as moderators of the response to sertraline treatment.
    Kranzler HR; Feinn R; Armeli S; Tennen H
    Alcohol Clin Exp Res; 2012 Mar; 36(3):509-16. PubMed ID: 21895712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype.
    Pettinati HM; Volpicelli JR; Kranzler HR; Luck G; Rukstalis MR; Cnaan A
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1041-9. PubMed ID: 10924008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.
    Kranzler HR; Armeli S; Tennen H; Covault J; Feinn R; Arias AJ; Pettinati H; Oncken C
    J Clin Psychopharmacol; 2011 Feb; 31(1):22-30. PubMed ID: 21192139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence.
    Kranzler HR; Armeli S; Tennen H
    Alcohol Clin Exp Res; 2012 Apr; 36(4):739-44. PubMed ID: 21981418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.
    Kenna GA; Zywiak WH; McGeary JE; Leggio L; McGeary C; Wang S; Grenga A; Swift RM
    Alcohol Clin Exp Res; 2009 Feb; 33(2):315-23. PubMed ID: 19032576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity.
    Kranzler HR; Armeli S; Tennen H; Covault J
    Addict Biol; 2013 Nov; 18(6):1024-31. PubMed ID: 23145795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder.
    Brady KT; Sonne S; Anton RF; Randall CL; Back SE; Simpson K
    Alcohol Clin Exp Res; 2005 Mar; 29(3):395-401. PubMed ID: 15770115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.
    Kenna GA; Zywiak WH; Swift RM; McGeary JE; Clifford JS; Shoaff JR; Vuittonet C; Fricchione S; Brickley M; Beaucage K; Haass-Koffler CL; Leggio L
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1567-74. PubMed ID: 24773166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy.
    Dundon W; Lynch KG; Pettinati HM; Lipkin C
    Alcohol Clin Exp Res; 2004 Jul; 28(7):1065-73. PubMed ID: 15252293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in response to sertraline pharmacotherapy in Type A alcohol dependence.
    Pettinati HM; Dundon W; Lipkin C
    Am J Addict; 2004; 13(3):236-47. PubMed ID: 15370943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different phenotypic and genotypic presentations in alcohol dependence: age at onset matters.
    Chen YC; Prescott CA; Walsh D; Patterson DG; Riley BP; Kendler KS; Kuo PH
    J Stud Alcohol Drugs; 2011 Sep; 72(5):752-62. PubMed ID: 21906503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism.
    Roache JD; Wang Y; Ait-Daoud N; Johnson BA
    Alcohol Clin Exp Res; 2008 Aug; 32(8):1502-12. PubMed ID: 18565156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-site study of alcohol subtypes: classification and overlap of unidimensional and multi-dimensional typologies.
    Epstein EE; Labouvie E; McCrady BS; Jensen NK; Hayaki J
    Addiction; 2002 Aug; 97(8):1041-53. PubMed ID: 12144607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on comparison of alcoholism subtypes as moderators of the response to sertraline treatment.
    Roache JD
    Alcohol Clin Exp Res; 2012 Apr; 36(4):561-3. PubMed ID: 22432698
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective follow-up of empirically derived Alcohol Dependence subtypes in wave 2 of the National Epidemiologic Survey on Alcohol And Related Conditions (NESARC): recovery status, alcohol use disorders and diagnostic criteria, alcohol consumption behavior, health status, and treatment seeking.
    Moss HB; Chen CM; Yi HY
    Alcohol Clin Exp Res; 2010 Jun; 34(6):1073-83. PubMed ID: 20374206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of alcoholism subtypes with a functional promoter polymorphism in the serotonin transporter protein gene.
    Kranzler H; Lappalainen J; Nellissery M; Gelernter J
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1330-5. PubMed ID: 12351926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the gene encoding the serotonin transporter is associated with a measure of sociopathy in alcoholics.
    Herman AI; Conner TS; Anton RF; Gelernter J; Kranzler HR; Covault J
    Addict Biol; 2011 Jan; 16(1):124-32. PubMed ID: 20192950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alcoholism typology on response to naltrexone in the COMBINE study.
    Bogenschutz MP; Scott Tonigan J; Pettinati HM
    Alcohol Clin Exp Res; 2009 Jan; 33(1):10-8. PubMed ID: 18828797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetically driven treatments for alcoholism: are we there yet?
    Arias AJ; Sewell RA
    CNS Drugs; 2012 Jun; 26(6):461-76. PubMed ID: 22587755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.
    Johnson BA; Ait-Daoud N; Seneviratne C; Roache JD; Javors MA; Wang XQ; Liu L; Penberthy JK; DiClemente CC; Li MD
    Am J Psychiatry; 2011 Mar; 168(3):265-75. PubMed ID: 21247998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.